- Home
- SELF vs PMVP Comparison
SELF vs PMVP Comparison
Compare SELF & PMVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SELF | PMVP |
|---|---|---|
| Founded | 1983 | 2013 |
| Country | United States | United States |
| Employees | 36 | N/A |
| Industry | Real Estate Investment Trusts | Medicinal Chemicals and Botanical Products |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.4M | 66.1M |
| IPO Year | 1997 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SELF | PMVP |
|---|---|---|
| Price | $5.05 | $1.34 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | 26.1K | ★ 708.0K |
| Earning Date | 05-08-2026 | 05-08-2026 |
| Dividend Yield | ★ 5.25% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.11 | N/A |
| Revenue | ★ $12,705,245.00 | N/A |
| Revenue This Year | $3.04 | N/A |
| Revenue Next Year | $3.47 | N/A |
| P/E Ratio | $45.55 | ★ N/A |
| Revenue Growth | ★ 1.40 | N/A |
| 52 Week Low | $4.73 | $1.02 |
| 52 Week High | $5.75 | $1.88 |
Technical Indicators
Market Signals| Indicator | SELF | PMVP |
|---|---|---|
| Relative Strength Index (RSI) | 36.01 | 50.07 |
| Support Level | N/A | $1.06 |
| Resistance Level | $5.23 | $1.50 |
| Average True Range (ATR) | 0.10 | 0.09 |
| MACD | -0.02 | -0.00 |
| Stochastic Oscillator | 0.00 | 42.11 |
Price Performance
Historical ComparisonAbout SELF Global Self Storage Inc.
Global Self Storage Inc is a self-administered and self-managed REIT that owns, operates, manages, acquires, develops, and redevelops self-storage properties. The company's self-storage properties are designed to offer affordable, easily accessible, and secure storage space for residential and commercial customers. It has one segment of Rental operations. Through its wholly-owned subsidiaries, the company owns and/or manages close to thirteen self-storage properties in Connecticut, Illinois, Indiana, New York, Ohio, Pennsylvania, South Carolina, and Oklahoma.
About PMVP PMV Pharmaceuticals Inc.
PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.